Delivra has been engaged by multiple clinicians to repurpose existing and globally accepted pharmaceutical drugs for new indications using our proprietary transdermal technology.
Pharmacy compounding, a multi-billion-dollar industry, is the formulation of approved oral pharmaceutical drugs into topical creams for patients that require unique therapies or to avoid side-effects related to oral use.
An agreement with NKS-Health is currently in place to allow clinicians to order Delivra-custom prescriptions. Please contact [email protected] delivrainc.com if you wish to be put in contact with NKS-Health.
Over 50% of patients with diabetes have some form of neuropathy and myofascial pain. Delivra has compounded a triple mix consisting of gabapentin, amitriptyline and clonidine for sufferers of moderate to severe nerve pain. Thousands of patients have found significant relief with this and other formulations offered by Delivra compounded products for diabetic and peripheral neuropathy. In addition, Delivra offers 4% Ibuprofen and 8% Celebrex, compounded in Delivra Base Cream, for patients with moderate to severe myofascial pain, including, osteoarthritis and rheumatoid arthritis.